ea0011p551 | Endocrine tumours and neoplasia | ECE2006
Pasquali D
, Conzo G
, Rossi V
, Bellastella G
, Maione L
, Bellastella A
, Sinisi AA
The stable somatostatin analog octreotide has been successfully used for imaging and treatment of a variety of human tumors. Octreotide treatment has been reported of limited value in pheochromocytoma (PHEO). PHEOs often express more than one somatostatin receptor, and it is uncertain by which receptor subtype the functional responses of octreotide are mediated. A recent study showed by immunohistochemical staining that vast majority of tumors (90%) were positive for sst(3), i...